Heidi De Wet

Prof. Heidi De Wet

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ADAnabelle Decottignies
Anabelle Decottignies
AGAlthea M. Grant
Althea M. Grant
JNJ. Wylie Nichols
J. Wylie Nichols
HWHeidi De Wet
Heidi De Wet
DMDavid B. McIntosh
David B. McIntosh
AGAndré Goffeau
André Goffeau
The Saccharomyces cerevisiae genome encodes 15 full-size ATPbinding cassette transporters (ABC), of whichPDR5, SNQ2, and YOR1 are known to be regulated by the transcription factors Pdr1p and Pdr3p (pleiotropic drug resistance). We have identified two new ABC transporter-encoding genes,PDR10 and PDR15, which were up-regulated by thePDR1–3 mutation. These genes, as well as four other ABC transporter-encoding genes, were deleted in order to study the properties of Yor1p. The PDR1–3 gain-of-function mutant was then used to overproduce Yor1p up to 10% of the total plasma membrane proteins. Overexpressed Yor1p was photolabeled by [γ-32P]2′,3′-O-(2,4,6-trinitrophenyl)-8-azido-ATP (K 0.5 = 45 μm) and inhibited by ATP (K D = 0.3 mm) in plasma membranes. Solubilization and partial purification on sucrose gradient allowed to detect significant Yor1p ATP hydrolysis activity (∼100 nmol of Pi·min−1·mg−1). This activity was phospholipid-dependent and sensitive to low concentrations of vanadate (I50 = 0.3 μm) and oligomycin (I50 = 8.5 μg/ml). In vivo, we observed a correlation between the amount of Yor1p in the plasma membrane and the level of resistance to oligomycin. We also demonstrated that Yor1p drives an energy-dependent, proton uncoupler-insensitive, cellular extrusion of rhodamine B. Furthermore, cells lacking both Yor1p and Pdr5p (but not Snq2p) showed increased accumulation of the fluorescent derivative of 1-myristoyl-2-[6-(NBD)aminocaproyl]phosphatidylethanolamine. Despite their different topologies, both Yor1p and Pdr5p mediated the ATP-dependent translocation of similar drugs and phospholipids across the yeast cell membrane. Both ABC transporters exhibit ATP hydrolysis in vitro, but Pdr5p ATPase activity is about 15 times higher than that of Yor1p, which may indicate mechanistic or regulatory differences between the two enzymes.

6 November 2008 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Closed access
JAJussi Aittoniemi
Jussi Aittoniemi
CFConstantina Fotinou
Constantina Fotinou
TCTim J Craig
Tim J Craig
HWHeidi De Wet
Heidi De Wet
PPPeter Proks
Peter Proks
FAFrances M Ashcroft
Frances M Ashcroft
SUR1 is an ATP-binding cassette (ABC) transporter with a novel function. In contrast to other ABC proteins, it serves as the regulatory subunit of an ion channel. The ATP-sensitive (K ATP ) channel is an octameric complex of four pore-forming Kir6.2 subunits and four regulatory SUR1 subunits, and it links cell metabolism to electrical activity in many cell types. ATPase activity at the nucleotide-binding domains of SUR results in an increase in K ATP channel open probability. Conversely, ATP binding to Kir6.2 closes the channel. Metabolic regulation is achieved by the balance between these two opposing effects. Precisely how SUR1 talks to Kir6.2 remains unclear, but recent studies have identified some residues and domains that are involved in both physical and functional interactions between the two proteins. The importance of these interactions is exemplified by the fact that impaired regulation of Kir6.2 by SUR1 results in human disease, with loss-of-function SUR1 mutations causing congenital hyperinsulinism and gain-of-function SUR1 mutations leading to neonatal diabetes. This paper reviews recent data on the regulation of Kir6.2 by SUR1 and considers the molecular mechanisms by which SUR1 mutations produce disease.

24 November 2005 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MMMichael V Mikhailov
Michael V Mikhailov
JCJeff D Campbell
Jeff D Campbell
HWHeidi De Wet
Heidi De Wet
KSKenju Shimomura
Kenju Shimomura
BZBrittany Zadek
Brittany Zadek
FAFrances M Ashcroft
Frances M Ashcroft
ATP‐sensitive potassium (KATP) channels conduct potassium ions across cell membranes and thereby couple cellular energy metabolism to membrane electrical activity. Here, we report the heterologous expression and purification of a functionally active KATP channel complex composed of pore‐forming Kir6.2 and regulatory SUR1 subunits, and determination of its structure at 18 Å resolution by single‐particle electron microscopy. The purified channel shows ATP‐ase activity similar to that of ATP‐binding cassette proteins related to SUR1, and supports Rb+ fluxes when reconstituted into liposomes. It has a compact structure, with four SUR1 subunits embracing a central Kir6.2 tetramer in both transmembrane and cytosolic domains. A cleft between adjacent SUR1s provides a route by which ATP may access its binding site on Kir6.2. The nucleotide‐binding domains of adjacent SUR1 appear to interact, and form a large docking platform for cytosolic proteins. The structure, in combination with molecular modelling, suggests how SUR1 interacts with Kir6.2.

1 February 2002 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
APAttilio Di Pietro
Attilio Di Pietro
GCG. Conseil
G. Conseil
JPJosé M. Pérez-Victoria
José M. Pérez-Victoria
GDG. Dayan
G. Dayan
HBH. Baubichon-Cortay
H. Baubichon-Cortay
DBD. Barron
D. Barron

6 November 2017 in Obesity
Verified
Journal Article
Open access
PDF file
BSBrianna Stubbs
Brianna Stubbs
PCPete J. Cox
Pete J. Cox
RERhys D. Evans
Rhys D. Evans
MCMalgorzata Cyranka
Malgorzata Cyranka
KCKieran Clarke
Kieran Clarke
HWHeidi De Wet
Heidi De Wet
Objective: The ketones d‐β‐hydroxybutyrate (BHB) and acetoacetate are elevated during prolonged fasting or during a “ketogenic” diet. Although weight loss on a ketogenic diet may be associated with decreased appetite and altered gut hormone levels, it is unknown whether such changes are caused by elevated blood ketones. This study investigated the effects of an exogenous ketone ester (KE) on appetite.Methods: Following an overnight fast, subjects with normal weight (n = 15) consumed 1.9 kcal/kg of KE, or isocaloric dextrose (DEXT), in drinks matched for volume, taste, tonicity, and color. Blood samples were analyzed for BHB, glucose, insulin, ghrelin, glucagon‐like peptide 1 (GLP‐1), and peptide tyrosine tyrosine (PYY), and a three‐measure visual analogue scale was used to measure hunger, fullness, and desire to eat.Results: KE consumption increased blood BHB levels from 0.2 to 3.3 mM after 60 minutes. DEXT consumption increased plasma glucose levels between 30 and 60 minutes. Postprandial plasma insulin, ghrelin, GLP‐1, and PYY levels were significantly lower 2 to 4 hours after KE consumption, compared with DEXT consumption. Temporally related to the observed suppression of ghrelin, reported hunger and desire to eat were also significantly suppressed 1.5 hours after consumption of KE, compared with consumption of DEXT.Conclusions: Increased blood ketone levels may directly suppress appetite, as KE drinks lowered plasma ghrelin levels, perceived hunger, and desire to eat.

1 February 2003 in Endocrinology
Verified
Journal Article
Open access
PDF file
YEY. Engelbrecht
Y. Engelbrecht
HWHeidi De Wet
Heidi De Wet
KHK. Horsch
K. Horsch
CLC. R. Langeveldt
C. R. Langeveldt
FHF. S. Hough
F. S. Hough
PHP. A. Hulley
P. A. Hulley
A central feature of glucocorticoid (GC)-induced osteoporosis is decreased bone formation, secondary to decreased numbers of functional osteoblasts. We find that ERK activity is essential for serum-induced osteoblast proliferation in vitro because inhibition of MAPK/ERK kinase activity by U0126 completely abolished both serum-induced activation of ERK and proliferation of mouse (MBA-15.4) and human (MG-63) osteoblast cell lines. Dexamethasone (Dex) rapidly (<2 h) inhibits the sustained phase of ERK activation, required for nuclear shift and mitogenesis. This inhibition is reversed by cotreatment with the protein synthesis inhibitor, cycloheximide, and by the GC receptor antagonist, RU486, suggesting a classical transcriptional mechanism. Phosphatase activity was up-regulated by Dex treatment, and inhibition of ERK activity by Dex was also reversed by the protein tyrosine phosphatase inhibitor, vanadate. Coupled with the rapidity of Dex action, this indicates immediate-early gene phosphatase involvement, and we therefore used quantitative, real-time PCR to examine expression profiles of the dual-specificity MAPK phosphatases, MKP-1 and MKP-3. MKP-1, but not MKP-3, mRNA expression was 10-fold up-regulated in both mouse and human osteoblast cell lines within 30 min of Dex treatment and remained elevated for 24 h. MKP-1 protein was also markedly up-regulated following 1–8 h of Dex treatment, and this correlated precisely with dephosphorylation of ERK. Cell proliferation was impaired by Dex treatment, and this was reversed by both RU486 and vanadate. Therefore, MKP-1 up-regulation provides a novel and rapid mechanism, whereby GCs inhibit osteoblast proliferation.